(Q47296157)

13 January 2018

title

Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients (English)

1 reference

13 January 2018

1 reference

Hiroko Mori

1

1 reference

13 January 2018

Yosuke Okada

2

1 reference

13 January 2018

Tadashi Arao

3

1 reference

13 January 2018

Keiko Nishida

4

1 reference

13 January 2018

Yoshiya Tanaka

5

1 reference

13 January 2018

language of work or name

English

0 references

publication date

20 July 2012

1 reference

13 January 2018

published in

Advances in Therapy

1 reference

13 January 2018

volume

29

1 reference

13 January 2018

issue

7

1 reference

13 January 2018

page(s)

635-644

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/s12325-012-0032-x

exact match

0 references

cites work

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

An angiotensin II AT1 receptor antagonist, telmisartan augments glucose uptake and GLUT4 protein expression in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Impact of elevated blood pressure on mortality from all causes, cardiovascular diseases, heart disease and stroke among Japanese: 14 year follow-up of randomly selected population from Japanese -- Nippon data 80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Report of the committee on the classification and diagnostic criteria of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Insulin resistance predicts mortality in nondiabetic individuals in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Therapeutic potential of angiotensin II receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

Vascular protective effects by activation of nuclear receptor PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-012-0032-X

10.1007/S12325-012-0032-X

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018